1. Show article details.

    BRIEF-Phoenix Life Sciences Says Board Placed Martin Tindall On Indefinite, Unpaid Suspension From His Position As CEO

    Reuters – 9:40 AM ET 07/11/2019

    Phoenix Life Sciences International Ltd (PLSI) : * PHOENIX LIFE SCIENCES INTERNATIONAL (PLSI) - ON JULY 8, BOARD PLACED MARTIN TINDALL ON INDEFINITE, UNPAID SUSPENSION FROM HIS POSITION AS CEO - SEC FILING. * Phoenix Life Sciences International Ltd (PLSI) - CONCURRENTLY, BOARD OF DIRECTORS APPOINTED JANELLE MARSDEN, TO ROLE OF CHIEF EXECUTIVE OFFICER Source text: Further company coverage:

  2. Show article details.

    Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License

    GlobeNewswire – 9:00 AM ET 06/04/2019

    via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that it has signed a binding Memorandum of Understanding between the Company and the Ministry of Health on behalf of the Government of Vanuatu, located in the South Pacific.

  3. Show article details.

    Phoenix Life Sciences International Announces Presentation at MjMicro Cap Conference in Preparation to Uplist to the OTCQB Market

    GlobeNewswire – 9:00 AM ET 05/29/2019

    via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that it will be presenting at the MjMicro Cap Conference on June 25, 2019 at the Westin Grand Central in New York, New York in conjunction with the recently announced share offering and international expansion.

  4. Show article details.

    Phoenix Life Sciences International Announces Maturine Carlot-Tary as Director of Health and Nutrition

    GlobeNewswire – 9:00 AM ET 05/17/2019

    via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that Ms. Maturine Carlot-Tary has joined the Company as Director of Health and Nutrition.

  5. Show article details.

    Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference

    GlobeNewswire – 8:00 AM ET 05/01/2019

    via NEWMEDIAWIRE - Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that it will be executing a $40 million capital raise and presenting at the TABOR Family Office Conference in Sea Island, Georgia. The offering terms of Phoenix Life’s capital raise include a $40 million raise with a minimum subscription of 2,000 shares, or $25,000.

  6. Show article details.

    Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018

    GlobeNewswire – 9:00 AM ET 04/26/2019

    via NEWMEDIAWIRE – Phoenix Life Sciences International Limited , an international adaptive healthcare solutions company, today announced that it has completed filing its Form 10-Quarterly Reports and Form 10-K Annual Reports, including audited financial reports, with the Securities and Exchange Commission for the 2017 and 2018 fiscal years as part of the Company’s 2018 merger and consolidation.

  7. Show article details.

    Phoenix Life Sciences International Announces John Taleo as Company's Global Head of Security

    GlobeNewswire – 9:00 AM ET 04/16/2019

    via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that John Taleo has been appointed as the Company’s Global Head of Security. In advance of his retirement in February 2018, Taleo served as Acting Commissioner of the Vanuatu Police Service and dedicated 40 years of his career to the force’s service.

  8. Show article details.

    Phoenix Life Sciences International Announces Giving Pledge Commitment and Launch of The Global Health Initiative with Kylie OBrien Ph.D.

    GlobeNewswire – 9:00 AM ET 04/11/2019

    via NEWMEDIAWIRE – Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced the launch of The Global Health Initiative  and the appointment of Dr. Kylie O’Brien as Chief Executive Officer of the Foundation, commencing the next chapter of the founders’ vision of the Company.

  9. Show article details.

    Phoenix Life Sciences International Appoints Tekon Timothy Tumukon as Company's Head of Biosecurity Services

    GlobeNewswire – 11:58 AM ET 04/08/2019

    via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced the appointment of Tekon Timothy Tumukon as the Company’s Head of Biosecurity Services.

  10. Show article details.

    Phoenix Life Sciences International Announces Dr. Santus Wari as Company's National Head of Healthcare in the Republic of Vanuatu

    GlobeNewswire – 9:00 AM ET 03/28/2019

    via NEWMEDIAWIRE – Phoenix Life Sciences International Limited , an adaptive healthcare solutions company, today announced that Dr. Santus Wari has joined the company as Head of National Healthcare for the Republic of Vanuatu. Dr. Santus Wari is the former Acting Director of the Vanuatu Department of Curative & Hospital Services and former Vanuatu Ministry of Health Director General of Health.

Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

No events in the past 90 days

Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.